← Russell 3000 cross-section

PBH Prestige Consumer Healthcare Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-06, not restated
Healthcare

Scale

Market cap
$2.4bn
Revenue TTM
$1.1bn
Net income TTM
$172m
Free cash flow
$235m
Composite score
58.8
Sector rank
#1521

Valuation

P / E
14.2
EV / EBITDA
13.5
EV / sales
3.9
FCF yield
9.62%
Earnings yield vs 10-yr
2.30pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
15.6%
EBITDA margin
29.2%
ROE
9.0%
ROIC
7.6%
Revenue growth
-1.4%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

After adding a core brand to our portfolio, we seek to increase its sales, market share and distribution in both existing and new channels through our established retail distribution network. We pursue this growth through increased spending on advertising and marketing support, new sales and marketing strategies, improved packaging and formulations, and innovative development of brand extensions. Total revenues for the three months ended June 30, 2026 were $265.7 million, an increase of $16.2 million, or 6.5%, versus the three months ended June 30, 2025. …Prestige Consumer Healthcare Inc., 10-Q, period ended 2026-06-30, filed 2026-08-06

Read the full passage →